[Atherothrombosis : Novel therapeutic strategies]

O Soehnlein1,2,3

  • 1Institute for Cardiovascular Prevention, Ludwig Maximilians University Munich, Pettenkoferstr. 9, 80336, München, Deutschland. oliver.soehnlein@gmail.com.

Herz
|December 14, 2017
PubMed

Insights

Atherosclerosis, a leading cause of death, is a multifactorial inflammatory disease, not just lipid-driven. This review covers current treatments and emerging therapies for atherosclerosis and atherothrombosis.

Area of Science:

  • Cardiovascular Science
  • Inflammation Biology
  • Medical Research

Background:

  • Atherosclerosis and atherothrombosis are primary global mortality causes.
  • Recent findings reveal atherosclerosis as a multifactorial inflammatory process in large arteries, beyond lipid-driven mechanisms.

Purpose of the Study:

  • To review the mechanistic basis of atherosclerosis.
  • To summarize current therapeutic strategies for atherosclerosis.
  • To outline novel therapeutic options under investigation.

Main Methods:

  • Literature review of mechanistic studies on atherosclerosis.
  • Synopsis of current clinical treatment strategies.
  • Survey of ongoing clinical and experimental therapeutic trials.

Main Results:

  • Atherosclerosis involves complex inflammatory pathways in arterial walls.
  • Current treatments target lipid reduction and inflammation.
  • Several new therapeutic avenues are in development.

Conclusions:

  • Understanding atherosclerosis as an inflammatory disease is crucial for effective treatment.
  • A multi-targeted approach is necessary for managing atherosclerosis and atherothrombosis.
  • Ongoing research holds promise for improved therapeutic outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
374
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.3K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
383
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
315